David Conen is a trained internist and cardiologist from Basel, Switzerland. He also obtained a Master of Public Health degree from Harvard University in Boston, USA. Dr. Conen recently joined the Population Health Research Institute as a clinician scientist. He also is an associate professor of medicine at McMaster University in Hamilton, Ontario.
Dr. Conen is a clinical cardiologist with training in performing echocardiography. His research activities involves the conduct of large epidemiological cohort studies to study risk factors for the occurrence of atrial fibrillation and its consequences. He is also interested in clinical trials on therapies to prevent atrial fibrillation and the complications associated with the arrhythmia.
Dr. Conen has published a large number of manuscripts in leading scientific journals. He received numerous prestigious grants in Switzerland and is the Principal Investigator of a large national cohort study to assess the relationship between atrial fibrillation and cognitive decline (Swiss-AF). He also leads another large cohort study of young and healthy individuals (GAPP), with a key focus on assessing risk factors for the development of cardiovascular risk factors in the general population.
Publications are listed in chronological order by descending date. Link takes user to pubMed for publication details.